Seran Bioscience Raises $215M in Series C

Seran Bioscience has successfully raised $215M in a Series C from multiple investors.

Company Overview

Seran Bioscience is a HealthTech company headquartered in San Diego, CA, founded in 2019 with 150+ employees.

Biotech developing precision therapeutics for complex diseases

Fundraising Details

Amount Raised: $215M
Round Type: Series C
Date: 2025-09-18
Investors: Multiple investors

About Seran Bioscience

Biotech developing precision therapeutics for complex diseases The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: San Diego, CA
Founded: 2019
Team Size: 150+
Industry: HealthTech

What This Means

This funding round demonstrates strong investor confidence in Seran Bioscience's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Seran Bioscience's successful fundraising reflects the strong fundamentals and growth potential in this space.

Looking Ahead

With this new capital, Seran Bioscience is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2025-09-18. For more information about Seran Bioscience, visit their headquarters at San Diego, CA.